Table 4.
At the end of therapy OR (95% CI) | At the end of follow-up OR (95% CI) | |
ALT normalization | 0.65 (0.21, 2.01) | 3.19 (1.02, 10.61)a |
HBVDNA-negation | 0.62 (0.19, 1.94) | 3.94 (1.23, 13.69)b |
HBeAg-negation | 0.55 (0.17, 1.72) | 2.45 (0.77, 8.23) |
ALT normal/ HBeAg & HBVDNA-negation | 0.55 (0.17, 1.72) | 2.45 (0.77, 8.23) |
P < 0.05,
P < 0.01 vs IFN-α.